Nasdaq
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | — | — | — | — | — | — |
| Net income | $390.6M | $473.8M | $568.9M | $498.5M | $380.3M | $598.0M |
| Diluted EPS | $0.93 | $1.12 | $1.14 | $0.95 | $0.69 | $1.01 |
| Operating cash flow | $163.6M | $837.1M | $1.4B | $378.2M | $548.5M | $343.8M |
| Free cash flow | $139.0M | $797.7M | $1.4B | $302.1M | $532.4M | $325.7M |
| Gross margin | — | — | — | — | — | — |
| Operating margin | — | — | — | — | — | — |
| Net margin | — | — | — | — | — | — |
| Line item | Q3 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q3 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | — | — | — | — | — | — | — | — |
| Net income | $70.4M | $97.9M | $115.7M | $106.1M | $133.2M | $163.4M | $195.4M | $163.9M |
| Diluted EPS | $0.13 | $0.18 | $0.20 | $0.18 | $0.22 | $0.28 | $0.33 | $0.28 |
| Operating cash flow | $214.0M | -$157.2M | $392.2M | -$17.1M | $159.2M | $5.2M | $196.6M | $209.6M |
| Free cash flow | $211.3M | -$160.5M | $385.8M | -$20.2M | $156.0M | $2.3M | $187.5M | $208.2M |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | — | — | — | — | — | — | — | — |
| Net margin | — | — | — | — | — | — | — | — |
Headlines for VLYPN will appear here once the news feed is connected.
Consensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
No insider transactions in the last 12 months.
No insider transactions on file.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.